Gabriela Pereira Souza

Ms. Gabriela Pereira Souza

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
LGLucas Wamser Fonseca Gonzaga
Lucas Wamser Fonseca Gonzaga
BEBeatriz Monte Egito
Beatriz Monte Egito
JCJoão Bosco Costa Coelho
João Bosco Costa Coelho
GSGabriela Pereira Souza
Gabriela Pereira Souza
Frederico MartinsFrederico Martins
Frederico Martins
MFMARCOS FERRANTE
MARCOS FERRANTE
Background: A PBPK model allows the prediction of the concentration of drug amounts in different tissues and organs over time and can be used to simulate and optimize different therapeutic protocols in healthy and sick individuals. The objective of this work was to create a PBPK model to predict propofol doses for healthy canines and canines with hepatic impairment. Methods: The study methodology was divided into two major phases, in which the first phase consisted of creating the PBPK model for healthy canines, and in the second phase, this model was adjusted for canines with hepatic impairment. The model for healthy canines presented good predictive performance, evidenced by the value of the performance measure of the geometric mean fold error that ranged from 0.8 to 1.25, meeting the double error criterion. The simulated regimen for healthy canines, i.e., of 5 mg/kg (administered as a bolus) followed by a continuous infusion at a rate of 0.13 mg/kg/min, was sufficient and ensured that all simulated subjects achieved the target plasma concentration. Canines with 60% and 40% liver function had infusion rate adjustments to ensure that individuals did not exceed the therapeutic window for maintenance of anesthesia. Results: The results presented in this manuscript are suggestive of the effectiveness and practicality of a PBPK model for propofol in canines, with a particular focus on hepatic impairment.

1 January 2026 in Ciência Rural
Verified
Journal Article
Open access
GSGabriela Pereira Souza
Gabriela Pereira Souza
LGLucas Wamser Fonseca Gonzaga
Lucas Wamser Fonseca Gonzaga
PAPablo Henrique Silva Avelar
Pablo Henrique Silva Avelar
JCJelieny Aparecida Claudino
Jelieny Aparecida Claudino
MTMarilda Onghero Taffarel
Marilda Onghero Taffarel
MFMARCOS FERRANTE
MARCOS FERRANTE
The aim was to compare the administration of propofol via bolus or continuous infusion for anesthetic induction in dogs. Twenty-four healthy adult dogs were randomized into one of two groups: anesthetic induction with intravenous propofol as a 1 mg/kg bolus every 60 seconds (Group B) or continuous infusion at 1 mg/kg/min using a syringe pump (Group CI) following premedication with acepromazine (0.02 mg/kg) and methadone (0.3 mg/kg). The propofol dose, induction time, physiological variables, and the occurrence of myoclonus, hypotension, apnea, desaturation, and hypercapnia after anesthetic induction were evaluated. Independent numerical variables were compared using the Student’s t-test or Mann-Whitney test, while physiological variables were analyzed using repeated measures ANOVA or Friedman test, followed by post hoc comparisons. The significance level was set at P < 0.05. The propofol dose was lower in Group B than in Group CI (3 mg/kg [3 - 3.3] vs. 4.5 mg/kg [3.5 - 5.6], respectively, P = 0.002), and the induction time was shorter in Group B than in Group CI (3 min [3 - 3.25] vs. 4.5 min [3 - 6.25], respectively, P = 0.027) (median and interquartile range). There was no difference in adverse effects between the groups. It is concluded that administering propofol in a 1 mg/kg bolus every 60 seconds allows anesthetic induction with a lower dose and shorter time, with no difference in adverse effects compared to continuous infusion at 1 mg/kg/min.